Fate Therapeutics Inc (FATE)
3.895
-0.32
(-7.70%)
USD |
NASDAQ |
May 07, 13:12
Fate Therapeutics Shares Outstanding: 99.24M for Feb. 20, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 20, 2024 | 99.24M |
December 31, 2023 | 98.63M |
October 31, 2023 | 98.60M |
September 30, 2023 | 98.59M |
August 02, 2023 | 98.56M |
June 30, 2023 | 98.52M |
April 27, 2023 | 98.38M |
April 11, 2023 | 98.21M |
March 31, 2023 | 98.19M |
February 22, 2023 | 98.16M |
December 31, 2022 | 97.29M |
October 27, 2022 | 97.17M |
September 30, 2022 | 97.11M |
July 28, 2022 | 97.00M |
June 30, 2022 | 96.86M |
April 28, 2022 | 96.63M |
April 12, 2022 | 96.58M |
March 31, 2022 | 96.54M |
February 24, 2022 | 96.43M |
January 31, 2022 | 96.36M |
December 31, 2021 | 95.73M |
October 28, 2021 | 95.49M |
September 30, 2021 | 95.36M |
August 02, 2021 | 95.18M |
June 30, 2021 | 94.27M |
Date | Value |
---|---|
May 03, 2021 | 94.04M |
April 05, 2021 | 93.89M |
March 31, 2021 | 93.89M |
February 22, 2021 | 93.78M |
January 31, 2021 | 93.68M |
January 08, 2021 | 92.84M |
December 31, 2020 | 87.72M |
November 03, 2020 | 87.24M |
September 30, 2020 | 87.00M |
August 03, 2020 | 86.84M |
June 30, 2020 | 86.80M |
June 11, 2020 | 86.57M |
May 07, 2020 | 77.69M |
March 31, 2020 | 76.00M |
March 06, 2020 | 75.94M |
February 28, 2020 | 75.93M |
January 27, 2020 | 75.83M |
December 31, 2019 | 75.73M |
November 04, 2019 | 75.59M |
September 30, 2019 | 75.42M |
September 18, 2019 | 75.28M |
August 05, 2019 | 65.39M |
June 30, 2019 | 65.31M |
May 06, 2019 | 65.19M |
March 31, 2019 | 65.12M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
65.31M
Minimum
Jun 30 2019
99.24M
Maximum
Feb 20 2024
90.16M
Average
94.72M
Median
Shares Outstanding Benchmarks
Amicus Therapeutics Inc | 295.38M |
Sarepta Therapeutics Inc | 94.52M |
ADMA Biologics Inc | 228.22M |
Ocular Therapeutix Inc | 148.63M |
Viking Therapeutics Inc | 110.27M |